ZVSA Annual EBITDA
-$14.41 M
-$800.20 K-5.88%
01 December 2023
Summary:
As of January 23, 2025, ZVSA annual earnings before interest, taxes, depreciation & amortization is -$14.41 million, with the most recent change of -$800.20 thousand (-5.88%) on December 1, 2023. During the last 3 years, it has fallen by -$2.25 million (-18.54%). ZVSA annual EBITDA is now -98.70% below its all-time high of -$7.25 million, reached on December 31, 2021.ZVSA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVSA Quarterly EBITDA
-$2.27 M
+$483.50 K+17.57%
01 September 2024
Summary:
As of January 23, 2025, ZVSA quarterly earnings before interest, taxes, depreciation & amortization is -$2.27 million, with the most recent change of +$483.50 thousand (+17.57%) on September 1, 2024. Over the past year, it has increased by +$556.10 thousand (+19.69%). ZVSA quarterly EBITDA is now -37.30% below its all-time high of -$1.65 million, reached on September 1, 2021.ZVSA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVSA TTM EBITDA
-$9.62 M
+$632.20 K+6.17%
01 September 2024
Summary:
As of January 23, 2025, ZVSA TTM earnings before interest, taxes, depreciation & amortization is -$9.62 million, with the most recent change of +$632.20 thousand (+6.17%) on September 1, 2024. Over the past year, it has increased by +$3.03 million (+23.95%). ZVSA TTM EBITDA is now -482.21% below its all-time high of -$1.65 million, reached on September 1, 2021.ZVSA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVSA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.9% | +19.7% | +23.9% |
| 3 y3 years | -18.5% | -20.6% | -8.4% |
| 5 y5 years | -18.5% | -20.6% | -8.4% |
ZVSA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.7% | at low | -28.7% | +55.9% | -181.7% | +46.3% |
| 5 y | 5-year | -98.7% | at low | -37.3% | +55.9% | -482.2% | +46.3% |
| alltime | all time | -98.7% | at low | -37.3% | +55.9% | -482.2% | +46.3% |
ZyVersa Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.27 M(-17.6%) | -$9.62 M(-6.2%) |
| June 2024 | - | -$2.75 M(-2.6%) | -$10.25 M(-18.9%) |
| Mar 2024 | - | -$2.82 M(+59.2%) | -$12.64 M(-12.3%) |
| Dec 2023 | -$14.41 M(+5.9%) | -$1.77 M(-38.8%) | -$14.41 M(-16.2%) |
| Sept 2023 | - | -$2.90 M(-43.7%) | -$17.19 M(-4.0%) |
| June 2023 | - | -$5.15 M(+12.2%) | -$17.91 M(+22.3%) |
| Mar 2023 | - | -$4.59 M(+0.9%) | -$14.64 M(+7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$13.61 M(+87.7%) | -$4.55 M(+25.7%) | -$13.63 M(+25.7%) |
| Sept 2022 | - | -$3.62 M(+92.5%) | -$10.84 M(+22.2%) |
| June 2022 | - | -$1.88 M(-47.4%) | -$8.87 M(+26.9%) |
| Mar 2022 | - | -$3.58 M(+103.1%) | -$6.99 M(+104.8%) |
| Dec 2021 | -$7.25 M(-40.3%) | - | - |
| Dec 2021 | - | -$1.76 M(+6.7%) | -$3.41 M(+106.7%) |
| Sept 2021 | - | -$1.65 M | -$1.65 M |
| Dec 2020 | -$12.16 M | - | - |
FAQ
- What is ZyVersa Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual EBITDA year-on-year change?
- What is ZyVersa Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly EBITDA year-on-year change?
- What is ZyVersa Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics TTM EBITDA year-on-year change?
What is ZyVersa Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ZVSA is -$14.41 M
What is the all time high annual EBITDA for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$7.25 M
What is ZyVersa Therapeutics annual EBITDA year-on-year change?
Over the past year, ZVSA annual earnings before interest, taxes, depreciation & amortization has changed by -$800.20 K (-5.88%)
What is ZyVersa Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ZVSA is -$2.27 M
What is the all time high quarterly EBITDA for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.65 M
What is ZyVersa Therapeutics quarterly EBITDA year-on-year change?
Over the past year, ZVSA quarterly earnings before interest, taxes, depreciation & amortization has changed by +$556.10 K (+19.69%)
What is ZyVersa Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ZVSA is -$9.62 M
What is the all time high TTM EBITDA for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$1.65 M
What is ZyVersa Therapeutics TTM EBITDA year-on-year change?
Over the past year, ZVSA TTM earnings before interest, taxes, depreciation & amortization has changed by +$3.03 M (+23.95%)